Sign up to save your podcasts
Or
Share Conversations with Raven S2EP6
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Conversations with Raven S2EP6
Update on the previous episode with the current data. Also, transportation and international information for the regions.
Mahe Ohna ✌️ Favour ALL
[email protected]
NIPAH exercise link:
https://publichealthpolicyjournal.com/federal-report-simulates-july-4th-2025-bioterror-attack-as-the-fda-goes-rogue/
Ravens's Music Videos Playlist:
https://youtube.com/playlist?list=PLoFIKheyukLDwQhUdgNrTCgnwHw7LC8gc&feature=shared
Raven's Music on YT (all five LPs vailable on almost all music streaming platforms):
https://youtube.com/channel/UCC0bhTADohUTFJg9rqkjF3A?feature=shared
Raven's Laugh Podcasts
https://www.spreaker.com/podcast/laugh-podcasts--5686542
Buy me a coffee to keep my technology and service active?
https://ko-fi.com/ravenkeefer
From India NIH:
The NiV genome codes for six structural proteins, namely, fusion protein (F), attachment glycoprotein (G), matrix protein (M), phosphoprotein (P), nucleoprotein (N), and the large RNA-dependent RNA polymerase protein (L). Further, the P gene codes for three non-structural proteins that include proteins C, W, and V (Fig. 5) (Sun et al. 2018). The N, P, and L proteins, in conjunction with the viral RNA, form the virus ribonucleoprotein (vRNP) complex, that regulates transcription of the viral genome and viral replication (Ranadheera et al. 2018) The NiV F protein is heavily glycosylated and mediates viral entry and integration into the host membrane (Aguilar et al. 2006). Studies have confirmed that altering the glycosylation pattern in F protein diminishes its fusion efficacy. At the same time, different investigations have reported that the N-glycans on NiV G glycoprotein act as a decoy and protect the viral envelope from antibody-mediated neutralization. (emphasis:-- hardened G glycoprotein acting as decoy preventing antibiotic and anti-body from mediation, dead giveaway and perhaps, the attempt to blame bats again? as proof of gain of function. Locations also happening to be where CDC or contractor labs are working on the specific pathogens? MERS isn't any different.)
Mahe Ohna ✌️ Favour ALL
[email protected]
NIPAH exercise link:
https://publichealthpolicyjournal.com/federal-report-simulates-july-4th-2025-bioterror-attack-as-the-fda-goes-rogue/
Ravens's Music Videos Playlist:
https://youtube.com/playlist?list=PLoFIKheyukLDwQhUdgNrTCgnwHw7LC8gc&feature=shared
Raven's Music on YT (all five LPs vailable on almost all music streaming platforms):
https://youtube.com/channel/UCC0bhTADohUTFJg9rqkjF3A?feature=shared
Raven's Laugh Podcasts
https://www.spreaker.com/podcast/laugh-podcasts--5686542
Buy me a coffee to keep my technology and service active?
https://ko-fi.com/ravenkeefer
From India NIH:
The NiV genome codes for six structural proteins, namely, fusion protein (F), attachment glycoprotein (G), matrix protein (M), phosphoprotein (P), nucleoprotein (N), and the large RNA-dependent RNA polymerase protein (L). Further, the P gene codes for three non-structural proteins that include proteins C, W, and V (Fig. 5) (Sun et al. 2018). The N, P, and L proteins, in conjunction with the viral RNA, form the virus ribonucleoprotein (vRNP) complex, that regulates transcription of the viral genome and viral replication (Ranadheera et al. 2018) The NiV F protein is heavily glycosylated and mediates viral entry and integration into the host membrane (Aguilar et al. 2006). Studies have confirmed that altering the glycosylation pattern in F protein diminishes its fusion efficacy. At the same time, different investigations have reported that the N-glycans on NiV G glycoprotein act as a decoy and protect the viral envelope from antibody-mediated neutralization. (emphasis:-- hardened G glycoprotein acting as decoy preventing antibiotic and anti-body from mediation, dead giveaway and perhaps, the attempt to blame bats again? as proof of gain of function. Locations also happening to be where CDC or contractor labs are working on the specific pathogens? MERS isn't any different.)
View all episodes
By Raven KeeferUpdate on the previous episode with the current data. Also, transportation and international information for the regions.
Mahe Ohna ✌️ Favour ALL
[email protected]
NIPAH exercise link:
https://publichealthpolicyjournal.com/federal-report-simulates-july-4th-2025-bioterror-attack-as-the-fda-goes-rogue/
Ravens's Music Videos Playlist:
https://youtube.com/playlist?list=PLoFIKheyukLDwQhUdgNrTCgnwHw7LC8gc&feature=shared
Raven's Music on YT (all five LPs vailable on almost all music streaming platforms):
https://youtube.com/channel/UCC0bhTADohUTFJg9rqkjF3A?feature=shared
Raven's Laugh Podcasts
https://www.spreaker.com/podcast/laugh-podcasts--5686542
Buy me a coffee to keep my technology and service active?
https://ko-fi.com/ravenkeefer
From India NIH:
The NiV genome codes for six structural proteins, namely, fusion protein (F), attachment glycoprotein (G), matrix protein (M), phosphoprotein (P), nucleoprotein (N), and the large RNA-dependent RNA polymerase protein (L). Further, the P gene codes for three non-structural proteins that include proteins C, W, and V (Fig. 5) (Sun et al. 2018). The N, P, and L proteins, in conjunction with the viral RNA, form the virus ribonucleoprotein (vRNP) complex, that regulates transcription of the viral genome and viral replication (Ranadheera et al. 2018) The NiV F protein is heavily glycosylated and mediates viral entry and integration into the host membrane (Aguilar et al. 2006). Studies have confirmed that altering the glycosylation pattern in F protein diminishes its fusion efficacy. At the same time, different investigations have reported that the N-glycans on NiV G glycoprotein act as a decoy and protect the viral envelope from antibody-mediated neutralization. (emphasis:-- hardened G glycoprotein acting as decoy preventing antibiotic and anti-body from mediation, dead giveaway and perhaps, the attempt to blame bats again? as proof of gain of function. Locations also happening to be where CDC or contractor labs are working on the specific pathogens? MERS isn't any different.)
Mahe Ohna ✌️ Favour ALL
[email protected]
NIPAH exercise link:
https://publichealthpolicyjournal.com/federal-report-simulates-july-4th-2025-bioterror-attack-as-the-fda-goes-rogue/
Ravens's Music Videos Playlist:
https://youtube.com/playlist?list=PLoFIKheyukLDwQhUdgNrTCgnwHw7LC8gc&feature=shared
Raven's Music on YT (all five LPs vailable on almost all music streaming platforms):
https://youtube.com/channel/UCC0bhTADohUTFJg9rqkjF3A?feature=shared
Raven's Laugh Podcasts
https://www.spreaker.com/podcast/laugh-podcasts--5686542
Buy me a coffee to keep my technology and service active?
https://ko-fi.com/ravenkeefer
From India NIH:
The NiV genome codes for six structural proteins, namely, fusion protein (F), attachment glycoprotein (G), matrix protein (M), phosphoprotein (P), nucleoprotein (N), and the large RNA-dependent RNA polymerase protein (L). Further, the P gene codes for three non-structural proteins that include proteins C, W, and V (Fig. 5) (Sun et al. 2018). The N, P, and L proteins, in conjunction with the viral RNA, form the virus ribonucleoprotein (vRNP) complex, that regulates transcription of the viral genome and viral replication (Ranadheera et al. 2018) The NiV F protein is heavily glycosylated and mediates viral entry and integration into the host membrane (Aguilar et al. 2006). Studies have confirmed that altering the glycosylation pattern in F protein diminishes its fusion efficacy. At the same time, different investigations have reported that the N-glycans on NiV G glycoprotein act as a decoy and protect the viral envelope from antibody-mediated neutralization. (emphasis:-- hardened G glycoprotein acting as decoy preventing antibiotic and anti-body from mediation, dead giveaway and perhaps, the attempt to blame bats again? as proof of gain of function. Locations also happening to be where CDC or contractor labs are working on the specific pathogens? MERS isn't any different.)